UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Criteria for the choice of anticoagulant therapy for the prevention of stroke in patients with atrial fibrillation early after the marketing of direct oral anticoagulants in Italy

European journal of internal medicine, 2017-06, Vol.41, p.e12-e14

2017

Link zum Volltext

Verfügbarkeit prüfen

Characterization of anp genetic variant rs5068 in chronic heart failure patients

Atherosclerosis, 2014-08, Vol.235 (2), p.e223-e223

2014

Link zum Volltext

Verfügbarkeit prüfen

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP

ATHEROSCLEROSIS, 2009, Vol.207 (1), p.e4-e4

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart

European heart journal, 2001-11, Vol.22 (22), p.2085-2103

2001

Link zum Volltext

Verfügbarkeit prüfen

Thrombolytic therapy in acute myocardial infarction

Journal of thrombosis and haemostasis, 2005-12, Vol.3 (12), p.2807-2808

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base

The Lancet (British edition), 1995-08, Vol.346 (8974), p.523-529

1995

Link zum Volltext

Verfügbarkeit prüfen

Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2012, Vol.34, p.303-310

2012

Link zum Volltext

Verfügbarkeit prüfen

Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2011, Vol.33, p.397-406

2011

Link zum Volltext

Verfügbarkeit prüfen

Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2010, Vol.32, p.363-369

2010

Link zum Volltext

Verfügbarkeit prüfen

85 Clinical characteristics and pattern of treatment of patients with renal dysfunction and chronic heart failure. Data from the GISSI Heart Failure Study

European journal of heart failure. Supplements, 2008-06, Vol.7 (Suppl_1), p.20-21

2008

Link zum Volltext

Verfügbarkeit prüfen

652 Atrial fibrillation is independently associated with more severe heart failure. Data from the GISSI Heart Failure Study

European journal of heart failure. Supplements, 2008-06, Vol.7 (Suppl_1), p.160-160

2008

Link zum Volltext

Verfügbarkeit prüfen

Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2009, Vol.31, p.339-343

2009

Link zum Volltext

Verfügbarkeit prüfen

Attributable Risks for Nonfatal Myocardial Infarction in Italy

Preventive medicine, 1995-11, Vol.24 (6), p.603-609

1995

Link zum Volltext

Verfügbarkeit prüfen

18 Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2007, Vol.29, p.194-201

2007

Link zum Volltext

Verfügbarkeit prüfen

Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2005, Vol.28, p.217-222

2005

Link zum Volltext

Verfügbarkeit prüfen

Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2003, Vol.26, p.223-229

2003

Link zum Volltext

Verfügbarkeit prüfen

Beta-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2004, Vol.27, p.203-208

2004

Link zum Volltext

Verfügbarkeit prüfen

Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer

Annals of oncology, 1990-09, Vol.1 (5), p.343-350

1990

Link zum Volltext

Verfügbarkeit prüfen

47 Sex differences in treatment of acute myocardial infarction

Controlled clinical trials, 1997-06, Vol.18 (3), p.S70-S70

1997

Link zum Volltext

Verfügbarkeit prüfen

β-adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2002, Vol.25, p.227-235

2002

Link zum Volltext

Verfügbarkeit prüfen

P22 Randomized and non-randomized patients in large clinical trials: The case of GISSI

Controlled clinical trials, 1996-04, Vol.17 (2), p.S104-S104

1996

Link zum Volltext

Verfügbarkeit prüfen

GISSI-2: mortality plus extensive left-ventricular damage as "end-point"

The Lancet (British edition), 1990-02, Vol.335 (8684), p.289-289

1990

Link zum Volltext

Verfügbarkeit prüfen

β-Adrenoceptor antagonists and antianginal drugs

Side Effects of Drugs Annual, 2001, Vol.24, p.220-228

2001

Link zum Volltext

Verfügbarkeit prüfen

40A The identification of predictive factors of missing follow-up in GISSI-3 trial

Controlled clinical trials, 1995-06, Vol.16 (3), p.55S-55S

1995

Link zum Volltext

Verfügbarkeit prüfen

Development of a computerized network for registration and randomization in a large-scale multicenter clinical trial

Controlled clinical trials, 1991-10, Vol.12 (5), p.691-692

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)
Buchkapitel
(20)

Sprache

Englisch
(52)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Criteria for the choice of anticoagulant therapy for the prevention of stroke in patients with atrial fibrillation early after the marketing of direct oral anticoagulants in Italy

Characterization of anp genetic variant rs5068 in chronic heart failure patients

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP

Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart

Thrombolytic therapy in acute myocardial infarction

Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base

Beta-adrenoceptor antagonists and antianginal drugs

Beta-adrenoceptor antagonists and antianginal drugs

Beta-adrenoceptor antagonists and antianginal drugs

85 Clinical characteristics and pattern of treatment of patients with renal dysfunction and chronic heart failure. Data from the GISSI Heart Failure Study

652 Atrial fibrillation is independently associated with more severe heart failure. Data from the GISSI Heart Failure Study

Beta-adrenoceptor antagonists and antianginal drugs

Attributable Risks for Nonfatal Myocardial Infarction in Italy

18 Beta-adrenoceptor antagonists and antianginal drugs

Beta-adrenoceptor antagonists and antianginal drugs

Beta-adrenoceptor antagonists and antianginal drugs

Beta-adrenoceptor antagonists and antianginal drugs

Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer

47 Sex differences in treatment of acute myocardial infarction

β-adrenoceptor antagonists and antianginal drugs

P22 Randomized and non-randomized patients in large clinical trials: The case of GISSI

GISSI-2: mortality plus extensive left-ventricular damage as "end-point"

β-Adrenoceptor antagonists and antianginal drugs

40A The identification of predictive factors of missing follow-up in GISSI-3 trial

Development of a computerized network for registration and randomization in a large-scale multicenter clinical trial

Suchergebnisse filtern